Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.

Takeuchi K, Smale S, Premchand P, Maiden L, Sherwood R, Thjodleifsson B, Bjornsson E, Bjarnason I.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):196-202.

PMID:
16469680
2.

Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.

Kvasnovsky CL, Aujla U, Bjarnason I.

Scand J Gastroenterol. 2015 Mar;50(3):255-63. doi: 10.3109/00365521.2014.966753. Epub 2014 Oct 14. Review.

PMID:
25314574
3.

Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

Kefalakes H, Stylianides TJ, Amanakis G, Kolios G.

Eur J Clin Pharmacol. 2009 Oct;65(10):963-70. doi: 10.1007/s00228-009-0719-3. Epub 2009 Aug 27. Review.

PMID:
19711064
5.
6.

Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.

Jaturapatporn D, Isaac MG, McCleery J, Tabet N.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD006378. doi: 10.1002/14651858.CD006378.pub2. Review.

PMID:
22336816
7.

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.

JAMA. 2000 Sep 13;284(10):1247-55.

PMID:
10979111
9.

Safe full-dose one-step nabumetone challenge in patients with nonsteroidal anti-inflammatory drug hypersensitivity.

Confino-Cohen R, Goldberg A.

Allergy Asthma Proc. 2003 Jul-Aug;24(4):281-4.

PMID:
12974196
10.

Selective COX-2 inhibitors and human inflammatory bowel disease.

McCartney SA, Mitchell JA, Fairclough PD, Farthing MJ, Warner TD.

Aliment Pharmacol Ther. 1999 Aug;13(8):1115-7.

11.
12.

Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.

Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.

Am J Med. 2005 Nov;118(11):1271-8.

PMID:
16271912
13.

Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.

Martín-García C, Hinojosa M, Berges P, Camacho E, García-Rodriguez R, Alfaya T.

J Investig Allergol Clin Immunol. 2003;13(1):20-5.

PMID:
12861847
15.

Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.

[No authors listed]

Prescrire Int. 2007 Dec;16(92):223-7.

PMID:
18084859
16.
17.

Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen.

Shah AA, Thjodleifsson B, Murray FE, Kay E, Barry M, Sigthorsson G, Gudjonsson H, Oddsson E, Price AB, Fitzgerald DJ, Bjarnason I.

Gut. 2001 Mar;48(3):339-46.

18.

Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.

Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B.

J Allergy Clin Immunol. 2003 May;111(5):1116-21.

PMID:
12743579
19.
20.

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.

Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.

Am J Gastroenterol. 2001 Apr;96(4):1019-27.

PMID:
11316141

Supplemental Content

Support Center